Retour sur lavenir.net
   VIOHALCO 17.660 € (+9,01 %)     UMICORE 21.700 € (+0,56 %)     CELYAD ONCOLOGY 0.231 € (-7,60 %)     VAN DE VELDE 30.000 € (+1,01 %)     GIMV 47.350 € (+0,21 %)     ASCENCIO 52.700 € (-1,13 %)     UCB 213.500 € (+0,66 %)     D'IETEREN GROUP 161.900 € (-2,06 %)     COLRUYT 38.920 € (+0,57 %)     ONTEX GROUP 2.090 € (-2,56 %)     KBC 132.950 € (-0,56 %)     TITAN S.A. 49.560 € (-0,56 %)     BPOST 1.178 € (-2,81 %)     BREDERODE 105.800 € (0,00 %)     ABO GROUP 4.000 € (-6,98 %)     AGEAS 74.950 € (-2,22 %)     HOME INVEST BE. 17.940 € (+0,22 %)     TINC 10.980 € (-0,36 %)     SYENSQO 79.050 € (+1,41 %)     GBL 74.550 € (+0,20 %)     KBC ANCORA 95.500 € (-0,31 %)     FAGRON 22.200 € (+1,14 %)     ECONOCOM GROUP 1.420 € (-0,35 %)     CMB.TECH 17.080 € (-1,39 %)     MONTEA 64.200 € (-0,31 %)     SIPEF 108.600 € (-0,91 %)     IMMOBEL 18.400 € (-0,81 %)     ONWARD MEDICAL 2.785 € (-4,13 %)     MELEXIS 69.850 € (+2,72 %)     TESSENDERLO 21.100 € (+3,43 %)     KINEPOLIS GROUP 50.800 € (+1,20 %)     EKOPAK 3.470 € (+0,29 %)     BARCO 7.495 € (+0,27 %)     CIE BOIS SAUVAGE 303.000 € (0,00 %)     HYLORIS 4.050 € (-3,57 %)     NYXOAH 1.250 € (-3,99 %)     SOLVAC NOM(RETAIL) 83.500 € (+1,83 %)     VASTNED 28.250 € (+0,18 %)     IBA 15.480 € (+0,13 %)     LOTUS BAKERIES 12 620.000 € (+1,12 %)     BEKAERT 38.350 € (+1,05 %)     XIOR 25.400 € (+0,20 %)     ELIA GROUP 120.400 € (+0,67 %)     RETAIL ESTATES 65.000 € (+0,15 %)     EVS 27.850 € (+2,01 %)     AB INBEV 68.340 € (+0,71 %)     FLUXYS BELGIUM D 22.200 € (0,00 %)     AGFA-GEVAERT 0.381 € (-0,39 %)     WAREHOUSES ESTATES 38.200 € (+2,41 %)     PROXIMUS 6.230 € (-2,50 %)     SOFINA 249.000 € (+1,06 %)     DECEUNINCK 2.500 € (+1,01 %)     JENSEN-GROUP 76.800 € (+2,13 %)     VGP 71.500 € (-0,28 %)     SOLVAY 25.360 € (+0,24 %)     SHURGARD 23.600 € (+0,43 %)     AEDIFICA 66.400 € (+0,91 %)     ORANGE BELGIUM 22.100 € (+0,45 %)     AZELIS GROUP 12.200 € (+1,92 %)     RECTICEL 12.720 € (+0,47 %)  
   CEGEDIM 11.000 € (+2,04 %)     L'OREAL 389.500 € (+1,49 %)     LVMH 401.950 € (-0,88 %)     STMICROELECTRONICS 46.600 € (+4,37 %)     KERING 232.000 € (+1,47 %)     DSM FIRMENICH AG 97.120 € (+2,95 %)     SBM OFFSHORE 36.340 € (+0,33 %)     ASML HOLDING 1 507.400 € (+1,76 %)     ASM INTERNATIONAL 860.800 € (+4,21 %)     ADYEN 903.000 € (+1,35 %)     ORANGE 14.395 € (-4,13 %)     ING GROEP N.V. 31.700 € (-1,48 %)     AUBAY 51.900 € (-1,14 %)     ESSILORLUXOTTICA 144.500 € (+2,30 %)     ENGIE 23.800 € (+0,46 %)     EURONEXT 158.400 € (-0,81 %)     ENOGIA 6.380 € (0,00 %)     PERNOD RICARD 60.640 € (+1,68 %)     ETHERO 0.920 € (+8,24 %)     ALTAREA 84.900 € (+0,24 %)     ELIOR GROUP 1.880 € (-3,04 %)     HEIJMANS KON 86.100 € (-3,26 %)     KAUFMAN ET BROAD 21.500 € (+1,90 %)     ALSTOM 15.270 € (+2,11 %)     BUREAU VERITAS 27.800 € (+2,39 %)     ALPES (COMPAGNIE) 17.700 € (-1,45 %)     SHELL PLC 41.010 € (+0,58 %)     TELEPERFORMANCE 70.100 € (+0,26 %)     BASIC-FIT 31.600 € (-1,86 %)     TIKEHAU CAPITAL 16.220 € (-2,99 %)     EUROCOMMERCIAL 27.250 € (+1,68 %)     DANONE 60.900 € (+1,06 %)     CSG 15.134 € (-0,51 %)     AEGON 7.832 € (-1,76 %)     74SOFTWARE 38.200 € (-0,78 %)     Vusion 133.000 € (+13,68 %)     HERMES INTL 1 355.000 € (+0,82 %)     PEUGEOT INVEST 51.400 € (-1,72 %)     PLANISWARE 23.550 € (-0,42 %)     BE SEMICONDUCTOR 191.900 € (+1,72 %)     SODEXO 57.400 € (+0,61 %)     BROADPEAK 2.210 € (+0,45 %)     BIOMERIEUX 73.250 € (+1,31 %)     ARKEMA 57.500 € (+2,04 %)     GTT 222.600 € (-0,62 %)     VALNEVA 2.831 € (-0,77 %)     GROUPE GUILLIN 20.300 € (-1,46 %)     AXA 43.910 € (-2,07 %)     EXOR NV 71.450 € (+0,35 %)     NEXITY 5.240 € (+3,25 %)     BENETEAU 5.260 € (+1,54 %)     UNILEVER 54.840 € (+1,22 %)     WORLDLINE 12.202 € (+1,68 %)     VOPAK 47.000 € (-1,51 %)     AMUNDI 92.750 € (-0,27 %)     SAINT GOBAIN 71.220 € (+1,60 %)     PHARMING GROUP 0.964 € (+3,92 %)     SANOFI 74.390 € (-0,27 %)     IMCD 95.180 € (+1,34 %)     ID LOGISTICS GROUP 324.500 € (+1,25 %)  
News Réglementées
17/09/2026 13:00

Medartis Group acquires M.A.R.C. Institute to establish its first surgical education center in the US

Medartis Holding AG / Key word(s): Takeover
Medartis Group acquires M.A.R.C. Institute to establish its first surgical education center in the US

17.09.2026 / 13:00 CET/CEST


PRESS RELEASE

  • The center in Doral, Florida, becomes the Group's first permanent training facility outside Europe and, with 36 surgical stations, its largest
  • The center will be managed independently by the current leadership team in partnership with the International Bone Research Association (IBRA)
  • The Institute will remain accessible to external participants like universities, medical societies, healthcare professionals and medical device companies
  • Together with leading universities, the M.A.R.C. Institute is also active in Brazil

WARSAW, Ind., and DORAL, Fla. — September 17, 2026: The Medartis Group today announced the acquisition of the M.A.R.C. Institute in Doral, Florida, one of the largest surgical training and bioskills research facilities in the world. The institute will retain its name and continue to operate under its existing leadership.

Founded in 2008 by surgeons, the M.A.R.C. Institute operates 36 fully equipped surgical stations and can host up to 140 participants at one time. It supports training and research in orthopedics and other medical specialties, spanning R&D and student education. The new ownership gives the center a long-term foundation. Its programmes and day-to-day operations will continue under the leadership of general manager Heloise Peixoto.

 

The Institute is situated in the immediate vicinity of Miami International Airport and offers hands-on training on anatomical specimens, providing surgeons with conditions close to those of the operating room. The Medartis Group intends to invest in modernizing the center, while keeping the center open throughout the renovation phase.

 

Its training content, research direction and academic standards continue to be shaped by the surgeon community it serves. Universities, medical societies, healthcare professionals, device manufacturers and other third parties can continue to book the facility for their own training and research programs, and existing bookings will be honored.

 

Together with leading universities, the M.A.R.C. Institute is also active in Brazil, with sites in São Paulo, Rio de Janeiro and Curitiba. These sites allow training and education activities to be delivered on a more decentralized basis, in a region in which the Medartis Group already has a direct presence with the brands Medartis und NeoOrtho.

 

"The US is a priority market for us and our fastest-growing region. Having our own training center there is a logical next step as we continue to invest in our two strategic pillars: innovation and education. Surgical training has been central to the way we work since Medartis was founded, and surgeons tend to adopt a system once they have worked with it themselves. With the M.A.R.C. Institute, we now have our own training center in the US, offering hands-on training with experienced faculty closer to surgeons across the Americas," said Matthias Schupp, CEO of Medartis.

 

"We are pleased to join the Medartis Group network, which brings deep experience in surgical education. Through this acquisition, the M.A.R.C. Institute's mission continues. Supported by planned investment in our infrastructure that will expand the range of courses the center can offer," said Al Weinstein, co-founder and former CEO of the M.A.R.C. Institute.

 

 

Your contact:

Medartis Holding AG, Corporate Communications, Hochbergerstrasse 60E, CH-4057 Basel

Fabian Hildbrand, Head of Corporate Communications,

email: investor.relations@medartis.com

Andreas Richter, Corporate Communications Manager,

email: corporate.communication@medartis.com

phone: +41 61 633 37 36 / +41 61 633 37 34

 

Medartis Inc., 1195 Polk Drive, Warsaw, IN 46582
Dave Temple, Executive Director Marketing Communications,

email: US_Corporate_Communications@medartis.com

phone: +1 574 635 3022

 

About the M.A.R.C. Institute

The Miami Anatomical Research Center (M.A.R.C. Institute), based in Doral, Florida, is a surgical training and bioskills research facility founded in 2008. 15-minutes away from the Miami International Airport, the center is within easy reach of participants travelling from North and South America. Its wet lab is built for hands-on training under realistic operating conditions using fresh-frozen specimens, with 36 fully equipped stations for up to 140 participants, scalable to smaller groups. CT scan capabilities as well as fracture simulation capabilities make the training experience even more realistic. Training and research activities cover orthopaedics and other medical specialties, and serve universities, medical societies, industry partners and individual surgeons. Further information: https://marc.institute/

 

About the Medartis Group

Founded in 1997 and headquartered in Basel, Switzerland, the Medartis Group is one of the world's leading manufacturers and providers of medical devices for surgical fixation of bone fractures and joint replacement for upper and lower extremities as well as for the craniomaxillofacial region. The Group has manufacturing sites in Switzerland, the United States, Brazil, France and Belgium. Medartis employs approx. 1,400 individuals across 13 countries, with products offered in over 60 countries globally. Medartis is committed to providing surgeons and operating theatre personnel with the most innovative implants and instruments as well as best-in-class service. For more information, please visit www.medartis.com.

 



End of Media Release
View original content: EQS News


Language:English
Company:Medartis Holding AG
Hochbergerstrasse 60E
4057 Basel
Switzerland
Phone:+41 61 633 34 34
Fax:+41 61 633 34 00
E-mail:info@medartis.com
Internet:www.medartis.com
ISIN:CH0386200239
Valor:38620023
Listed:SIX Swiss Exchange
EQS News ID:2400368

 
End of NewsEQS News Service

2400368  17.09.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière